Primary Recipient

UNIVERSITY OF WASHINGTON

Amount

$698,108.00

Award Date

5/21/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The primary goal of this project is to evaluate the role of FDG PET and its ability to predict early treatment response and drug resistance in advanced epithelial ovarian cancer (AOC). A vast majority of ovarian cancer patients present with advanced stag

Recipients Connected to Award

Recipient	Role	Amount
UNIVERSITY OF WASHINGTON	Primary recipient	$641,850.00
PHILIPS ELECTRONICS NORTH AMERICA CORPORATION	Sub-recipient	$56,258.00